NCT05164094 2025-05-15
A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults
ModernaTX, Inc.
Phase 1/2 Active not recruiting
ModernaTX, Inc.
Pediatric Transplantation & Cellular Therapy Consortium
National University Hospital, Singapore